OMS643762 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

8. ハンチントン病

---

臨床試験数 : 242 /  薬物数 : 205 - (DrugBank : 62) / 標的遺伝子数 : 85 - 標的パスウェイ数 : 159

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02074410 (ClinicalTrials.gov)	January 2014	21/2/2014	Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease	Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease	Huntington's Disease	Drug: OMS643762;Drug: Placebo	Omeros Corporation	NULL	Terminated	18 Years	65 Years	All	22	Phase 2	United States